Table 4.
Human papillomavirus (HPV) genotype distribution in breast cancer and CIN3+ tissue.
| SPF10LiPA25 |
Semi-Q-PCR |
|
|---|---|---|
| n(%) | n(%) | |
| CIN3+ samples, N = 93 | ||
| Single infections | ||
| HPV 16 | 42 (45.16) | 41 (44.09) |
| HPV 18 | 5 (5.38) | 6 (6.45) |
| HPV 31 | 9 (9.68) | 9 (9.68) |
| HPV 33 | 7 (7.53) | 7 (7.53) |
| HPV 35 | 1 (1.08) | 1 (1.08) |
| HPV 39 | 1 (1.08) | 1 (1.08) |
| HPV 45 | 8 (8.60) | 8 (8.60) |
| HPV 51 | 1 (1.08) | 1 (1.08) |
| HPV 52 | 4 (4.30) | 4 (4.30) |
| HPV 56 | 2 (2.15) | 2 (2.15) |
| HPV 58 | 3 (3.23) | 3 (3.23) |
| HPV 59 | 1 (1.08) | 1 (1.08) |
| Multiple infections | ||
| HPV 18 + 31 | 1 (1.08) | 1 (1.08) |
| HPV 45 + 52 | 1 (1.08) | 1 (1.08) |
| HPV 33 + 31 | 1 (1.08) | 1 (1.08) |
| HPV 58 + 45 | 1 (1.08) | 1 (1.08) |
| HPV-negative | 5 (5.38) | 5 (5.38) |
| Case group breast cancer, N = 93 | ||
| Single infections | ||
| HPV 16 | 1 (1.08) | 1 (1.08) |
| HPV 56 | 1(1.08) | |
| HPV-negative | 91 (97.85) | 92 (98.92) |
| Control group breast cancer, N = 100 | ||
| Single infections | ||
| HPV 16 | 1 (1.00) | 0 (0.00) |
| HPV-negative | 99 (99.00) | 100 (100.00) |
| Total | 286 | 286 |